Melinta Therapeutics Inc., of Morristown, N.J., which is focused on the development and commercialization of antibiotics, said it received the initial $75 million disbursement under a convertible loan facility from Vatera Healthcare Partners LLC. In addition, an amendment to the facility agreement with funds managed by Deerfield Management Co. LP also became effective.